Circulating interleukin-1β and interleukin-6 concentrations are closely associated with γ-glutamyltranspeptidase activity in middle-aged Japanese men without obvious cardiovascular diseases

Metabolism: Clinical and Experimental

Volumn 60, Issue 7, 2011, Pages 914-922

  Mochizuki, Kazuki ^a   Misaki, Yasumi ^a   Miyauchi, Rie ^a   Takabe, Satsuki ^a   Shimada, Masaya ^a   Miyoshi, Noriyuki ^a   Ichikawa, Yoko ^a   Goda, Toshinao ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIRCULATION; CONCENTRATION (PARAMETERS); CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; JAPANESE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SELF REPORT; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ALANINE TRANSAMINASE; ASIAN CONTINENTAL ANCESTRY GROUP; ASPARTATE AMINOTRANSFERASES; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIFE STYLE; MALE; MIDDLE AGED;

EID: 79959351119     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.08.011     Document Type: Article

References (41)

1. Vettor R, Milan G, Rossato M, Federspil G. Review article: adipocytokines and insulin resistance. Aliment Pharmacol Ther 2005;22(Suppl 2):3-10. (Pubitemid 41564373)
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20. (Pubitemid 34000785)
3. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-23. (Pubitemid 38620857)
4. Spranger J, Kroke A, Mohlig M, Hoffmann K, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003;52: 812-7. (Pubitemid 36323590)
5. Kim ES, Im JA, Kim KC, Park JH, et al. Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth. Obesity (Silver Spring) 2007;15:3023-30. (Pubitemid 351256664)
6. Bruun JM, Stallknecht B, Helge JW, Richelsen B. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol 2007;157:465-71. (Pubitemid 350018450)
7. Hoge M, Amar S. Role of interleukin-1 in bacterial atherogenesis. Drugs Today (Barc) 2006;42:683-8. (Pubitemid 44901642)
8. Mahmoudi M, Curzen N, Gallagher PJ. Atherogenesis: the role of inflammation and infection. Histopathology 2007;50:535-46. (Pubitemid 46495812)
9. Bastard JP, Jardel C, Bruckert E, Blondy P, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000;85: 3338-42.
10. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-14.
11. Deepa R, Velmurugan K, Arvind K, Sivaram P, et al. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance - the Chennai Urban Rural Epidemiology Study (CURES). Metabolism 2006;55:1232-8. (Pubitemid 44215943)
12. Matsushita K, Yatsuya H, Tamakoshi K, Wada K, et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 2006;26:871-6. (Pubitemid 43732165)
13. Misaki Y, Miyauchi R, Mochizuki K, Takabe S, et al. Plasma IL-1β concentrations are closely associated with fasting blood glucose levels in healthy and preclinical middle-aged, non-overweight and overweight Japanese men. Metabolism 2010;59(10):1465-71.
14. Ginn-Pease ME, Whisler RL. Redox signals and NF-kappaB activation in T cells. Free Radic Biol Med 1998;25:346-61. (Pubitemid 28326210)
15. Haddad JJ. Redox regulation of pro-inflammatory cytokines and IkappaB-α/NF-kappaB nuclear translocation and activation. Biochem Biophys Res Commun 2002;296:847-56.
16. Zhang J, Johnston G, Stebler B, Keller ET. Hydrogen peroxide activates NFkappaB and the interleukin-6 promoter through NFkappaB- inducing kinase. Antioxid Redox Signal 2001;3:493-504. (Pubitemid 32646039)
17. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 2003;26: 1589-96.
18. Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005;43:289-330. (Pubitemid 41095268)
19. Lieberman MW, Barrios R, Carter BZ, Habib GM, et al. γ-Glutamyl transpeptidase. What does the organization and expression of a multipromoter gene tell us about its functions?AmJ Pathol 1995;147:1175-85.
20. Pompella A, Corti A, Paolicchi A, Giommarelli C, et al. γ-Glutamyltransferase, redox regulation and cancer drug resistance. Curr Opin Pharmacol 2007;7:360-6. (Pubitemid 47289260)
21. Yamada J, Tomiyama H, Yambe M, Koji Y, et al. Elevated serum levels of alanine aminotransferase and γ-glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 2006;189:198-205. (Pubitemid 44441282)
22. Bo S, Gambino R, Durazzo M, Guidi S, et al. Associations between γ-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress. World J Gastroenterol 2005;11:7109-17. (Pubitemid 43154004)
23. Lee DH, Steffen LM, Jacobs Jr DR. Association between serum γ-glutamyltransferase and dietary factors: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr 2004;79:600-5. (Pubitemid 41103903)
24. Nakanishi N, Suzuki K, Tatara K. Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004;27:1427-32. (Pubitemid 38679993)
25. Kim CH, Park JY, Lee KU, Kim JH, et al. Association of serum γ-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver. Diabetes Metab Res Rev 2009;25:64-9.
26. Andre P, Balkau B, Born C, Charles MA, et al. Three-year increase of γ-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort. Diabetologia 2006;49:2599-603.
27. Meisinger C, Lowel H, Heier M, Schneider A, et al. Serum γ-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med 2005;258:527-35. (Pubitemid 41705393)
28. Murakami K, Mizoue T, Sasaki S, Ohta M, et al. Dietary intake of folate, other B vitamins, and ω-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults. Nutrition 2008;24:140-7. (Pubitemid 350299847)
29. Maedler K, Donath MY. β-Cells in type 2 diabetes: a loss of function and mass. Horm Res 2004;62(Suppl 3):67-73.
30. Larsen CM, Faulenbach M, Vaag A, Ehses JA, et al. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 2009;32:1663-8.
31. Larsen CM, Faulenbach M, Vaag A, Volund A, et al. Interleukin-1- receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356:1517-26. (Pubitemid 46588416)
32. Vozarova B, Stefan N, Lindsay RS, Saremi A, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002;51: 1889-95. (Pubitemid 34564303)
33. van Bruggen R, Koker MY, Jansen M, van Houdt M, et al. Human NLRP3 inflammasome activation is Nox1-4 independent. Blood 2010; 115:5398-400.
34. van de Veerdonk FL, Smeekens SP, Joosten LA, Kullberg BJ, et al. Reactive oxygen species-independent activation of the IL-1b inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci U S A 2010;107:3030-3.
35. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009;27:519-50.
36. Lachmann HJ, Lowe P, Felix SD, Rordorf C, et al. In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes. J Exp Med 2009;206:1029-36.
37. Baxmann AC, Ahmed MS, Marques NC, Menon VB, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008;3:348-54.
38. Niemela O. Biomarkers in alcoholism. Clin Chim Acta 2007;377:39-49. (Pubitemid 44908237)
39. Das SK, Vasudevan DM. Alcohol-induced oxidative stress. Life Sci 2007;81:177-87. (Pubitemid 46978376)
40. Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007;7:599-612. (Pubitemid 47106631)
41. GnacinskaM, Malgorzewicz S, Stojek M, Lysiak-Szydlowska W, et al. Role of adipokines in complications related to obesity: a review. Adv Med Sci 2009;54:150-7.